Stock listing
NASDAQ:IVVD Invivyd, Inc. Stock
Home listing (NASDAQ) of Invivyd, Inc.
Follow Invivyd, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IVVD
$0.582 USD -0.020 (-3.4%)
Close on Oct 30, 2026
- Day range
- $0.538 – $0.594 USDOct 30, 2026
- Volume
- 5.36M sharesOct 30, 2026
- Market cap
- $171.5M USDAt the close on Oct 30, 2026 · price × 294.8M shares outstanding
- 52-week range
- $0.528 – $3.070 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $4.03M USDMedian day 3.73M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IVVD · Home | $0.582 USD | -0.020 (-3.4%) | 5,361,494 | $0.562 | $0.594 | $0.538 | $0.602 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:IVVD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.582 | -0.020 | -3.4% | $0.562 | $0.594 | $0.538 | 5,361,494 | |
| $0.602 | -0.015 | -2.4% | $0.610 | $0.635 | $0.573 | 3,081,726 | |
| $0.617 | +0.028 | +4.7% | $0.589 | $0.626 | $0.577 | 2,895,195 | |
| $0.589 | 0.000 | -0.1% | $0.600 | $0.607 | $0.580 | 4,248,537 | |
| $0.589 | -0.024 | -3.9% | $0.630 | $0.630 | $0.581 | 2,827,018 | |
| $0.613 | +0.003 | +0.5% | $0.592 | $0.621 | $0.580 | 2,762,894 | |
| $0.610 | -0.029 | -4.6% | $0.644 | $0.663 | $0.589 | 4,317,151 | |
| $0.639 | +0.003 | +0.4% | $0.660 | $0.690 | $0.635 | 6,022,757 | |
| $0.637 | +0.027 | +4.4% | $0.622 | $0.651 | $0.617 | 2,273,319 | |
| $0.610 | -0.009 | -1.5% | $0.640 | $0.679 | $0.610 | 4,484,895 | |
| $0.619 | -0.050 | -7.5% | $0.670 | $0.680 | $0.611 | 3,450,500 | |
| $0.669 | +0.061 | +10.0% | $0.619 | $0.682 | $0.614 | 3,285,300 | |
| $0.608 | -0.038 | -5.9% | $0.640 | $0.640 | $0.601 | 3,999,700 | |
| $0.646 | -0.027 | -4.1% | $0.660 | $0.673 | $0.640 | 3,657,067 | |
| $0.673 | -0.048 | -6.6% | $0.710 | $0.717 | $0.663 | 2,825,203 | |
| $0.721 | +0.021 | +3.0% | $0.700 | $0.738 | $0.691 | 2,765,900 | |
| $0.700 | -0.029 | -4.0% | $0.740 | $0.740 | $0.670 | 10,440,900 | |
| $0.729 | -0.077 | -9.6% | $0.804 | $0.820 | $0.725 | 9,468,300 | |
| $0.806 | -0.033 | -3.9% | $0.852 | $0.854 | $0.800 | 5,048,800 | |
| $0.839 | +0.017 | +2.1% | $0.820 | $0.845 | $0.790 | 5,422,400 | |
| $0.822 | +0.005 | +0.6% | $0.835 | $0.844 | $0.770 | 7,129,000 | |
| $0.817 | -0.053 | -6.1% | $0.865 | $0.898 | $0.806 | 5,459,800 | |
| $0.870 | +0.020 | +2.4% | $0.855 | $0.879 | $0.821 | 8,385,700 | |
| $0.850 | -0.100 | -10.5% | $0.921 | $0.934 | $0.774 | 31,292,500 | |
| $0.950 | +0.016 | +1.7% | $0.976 | $1.010 | $0.940 | 11,005,200 | |
| $0.934 | +0.021 | +2.3% | $0.921 | $0.947 | $0.901 | 3,489,300 | |
| $0.913 | -0.010 | -1.1% | $0.950 | $0.970 | $0.890 | 6,000,000 | |
| $0.923 | -0.041 | -4.3% | $0.950 | $0.965 | $0.911 | 6,910,200 | |
| $0.964 | -0.056 | -5.5% | $1.010 | $1.010 | $0.910 | 8,439,300 | |
| $1.020 | +0.265 | +35.1% | $0.835 | $1.050 | $0.820 | 15,009,500 | |
| $0.755 | +0.009 | +1.2% | $0.756 | $0.786 | $0.731 | 6,277,700 | |
| $0.746 | -0.059 | -7.3% | $0.820 | $0.834 | $0.730 | 5,840,500 | |
| $0.805 | -0.025 | -3.0% | $0.830 | $0.840 | $0.801 | 3,587,600 | |
| $0.830 | -0.062 | -7.0% | $0.881 | $0.893 | $0.820 | 4,231,000 | |
| $0.892 | +0.106 | +13.5% | $0.820 | $0.936 | $0.802 | 3,801,600 | |
| $0.786 | +0.010 | +1.3% | $0.790 | $0.817 | $0.771 | 4,383,700 | |
| $0.776 | -0.021 | -2.6% | $0.782 | $0.815 | $0.770 | 1,896,700 | |
| $0.797 | -0.029 | -3.5% | $0.818 | $0.822 | $0.783 | 1,906,100 | |
| $0.826 | 0.000 | 0.0% | $0.849 | $0.863 | $0.810 | 2,088,700 | |
| $0.826 | -0.009 | -1.1% | $0.820 | $0.827 | $0.790 | 1,960,300 | |
| $0.835 | +0.031 | +3.9% | $0.835 | $0.847 | $0.803 | 2,576,600 | |
| $0.804 | -0.076 | -8.6% | $0.869 | $0.880 | $0.780 | 4,988,000 | |
| $0.880 | -0.075 | -7.9% | $0.860 | $0.901 | $0.753 | 12,570,200 | |
| $0.955 | -0.010 | -1.0% | $0.996 | $1.010 | $0.942 | 3,495,200 | |
| $0.965 | +0.065 | +7.2% | $0.910 | $0.970 | $0.894 | 3,630,400 | |
| $0.900 | -0.002 | -0.2% | $0.900 | $0.916 | $0.879 | 1,718,900 | |
| $0.902 | -0.037 | -3.9% | $0.923 | $0.923 | $0.843 | 3,627,200 | |
| $0.939 | -0.004 | -0.4% | $0.926 | $0.980 | $0.922 | 2,851,300 | |
| $0.943 | -0.054 | -5.4% | $0.970 | $0.975 | $0.910 | 4,052,500 | |
| $0.997 | +0.046 | +4.8% | $0.945 | $1.030 | $0.866 | 5,426,100 | |
| $0.951 | -0.009 | -0.9% | $1.015 | $1.050 | $0.934 | 8,550,800 | |
| $0.960 | +0.092 | +10.6% | $0.888 | $1.010 | $0.888 | 7,262,400 | |
| $0.868 | +0.127 | +17.1% | $0.760 | $0.875 | $0.752 | 7,745,800 | |
| $0.741 | +0.020 | +2.8% | $0.710 | $0.750 | $0.682 | 1,765,200 | |
| $0.721 | +0.035 | +5.1% | $0.690 | $0.726 | $0.660 | 2,030,100 | |
| $0.686 | -0.046 | -6.3% | $0.705 | $0.720 | $0.676 | 1,978,300 | |
| $0.732 | +0.044 | +6.5% | $0.707 | $0.738 | $0.670 | 1,685,400 | |
| $0.688 | +0.014 | +2.1% | $0.684 | $0.719 | $0.680 | 1,463,593 | |
| $0.673 | -0.067 | -9.0% | $0.740 | $0.750 | $0.663 | 3,253,001 | |
| $0.740 | +0.081 | +12.3% | $0.689 | $0.749 | $0.671 | 3,515,900 | |
| $0.659 | +0.055 | +9.1% | $0.610 | $0.670 | $0.609 | 3,265,300 | |
| $0.604 | +0.031 | +5.4% | $0.576 | $0.627 | $0.574 | 3,877,800 | |
| $0.573 | +0.021 | +3.8% | $0.552 | $0.596 | $0.552 | 4,409,400 | |
| $0.552 | +0.017 | +3.2% | $0.556 | $0.582 | $0.545 | 2,455,500 | |
| $0.535 | -0.047 | -8.1% | $0.582 | $0.598 | $0.528 | 2,303,800 | |
| $0.582 | +0.039 | +7.2% | $0.557 | $0.590 | $0.551 | 3,050,500 |
- Ticker
- NASDAQ:IVVD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
Latest earnings call · May 14, 2026
Invivyd (NASDAQ:IVVD) Q1 2026 Earnings Call
Replay and transcript
Latest deck · Sep 29, 2026
Corporate Update (September 2026)
Corporate update · 23 slides
Calls
Replays
Invivyd (NASDAQ:IVVD) Q1 2026 Earnings Call
Thu, May 14, 2026 · 8:30 AM ET
Watch TranscriptInvivyd (NASDAQ:IVVD) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 8:30 AM ET
Watch TranscriptInvivyd (NASDAQ:IVVD) Q3 2025 Earnings Call
Thu, Nov 06, 2025 · 8:30 AM ET
Watch Transcript
Latest news
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
Oct 21, 2026
Closed $0.639 (+0.4%) on Oct 21, 2026
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 5, 2026
Closed $0.839 (+2.1%) on Oct 5, 2026
Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
Sep 29, 2026
Closed $0.85 (-10.5%) on Sep 29, 2026
Invivyd to Participate in Upcoming September Investor Conferences
Sep 8, 2026
Closed $0.826 (0.0%) on Sep 8, 2026
Invivyd Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
Sep 4, 2026
Closed $0.826 (-1.1%) on Sep 4, 2026
Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
Sep 1, 2026
Closed $0.88 (-7.9%) on Sep 1, 2026
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 13, 2026
Closed $0.721 (+5.1%) on Aug 14, 2026
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 4, 2026
Aug 5, 2026
Closed $0.604 (+5.4%) on Aug 5, 2026
Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA
Jul 6, 2026
Closed $0.834 (-6.7%) on Jul 6, 2026
Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
Jun 16, 2026
Closed $0.892 (+2.6%) on Jun 16, 2026
Decks
Corporate Update (September 2026)
Corporate update · 23 slides · Sep 29, 2026
Q1 2026 Earnings Presentation
Earnings · 25 slides · May 14, 2026
Corporate Update (April 2026)
Corporate update · 19 slides · Apr 9, 2026
Q4 2025 Earnings Presentation
Earnings · 17 slides · Mar 5, 2026
Invivyd, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 38 in the last 12 months · 136 in all · newest Oct 21, 2026 · oldest 2022
- Calls
- 12 calls with a replay · 12 with a transcript · latest May 14, 2026
- Decks
- 29 decks · latest Sep 29, 2026
Where Invivyd, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IVVD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:IVVD | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Invivyd, Inc.